Navigation Links
Radial Endoscopic Ultrasound (EG-3630UR)

ProductsRadial Endoscopic Ultrasound (EG-3630UR)
Company PENTAX Medical Company
Item Radial Endoscopic Ultrasound (EG-3630UR)
Features 
  • Easy Orientation.
  • The World's First Forward View Observation Ultrasound Gastroscope.
  • The World's First Endoscope with Electronic Radial Scanning Capability.
  • One-touch Balloon Water Feed and Suction Operation
Description The EG-3630UR is a radial-type endoscope with a built-in electronic scanning system. This new technology gives a flicker-free, high-resolution image under echo. It is also equipped with an optical system for direct visual observation. The EG-3630UR has achieved the highest level of performance as an endoscope as well as exceptional ultrasound imaging capability. The maneuverability is as comfortable as conventional endoscopes because of the light control body. It comes standard with a large 2.4mm instrument channel to accommodate a bioptome or variety of other clinical instruments. It is Color Doppler compatible and Color Flow Angio capable, and a wide range of EUS examination is now possible with the EG-3630UR.
Info PENTAX Medical Company
Customer Service: (800) 431-5880
Web site: http://www.pentaxmedical.com

Related medicine products :

1. D-Stat Radial Hemostat Band
2. D-Stat Radial
3. FLEXOR CHECK-FLO Introducer Sets for Radial Artery Access with AQ Hydrophylic Coating
4. CHECK-FLO Performer Introducer Sets For Radial Artery Access
5. Swanson Titanium Radial Head Implants
6. Evolve Modular Radial Head System
7. rHead Radial Implant System
8. Modular Radial Head
9. RadiStop® Radial Compression System
10. Manual Radial Microtome - Economy Series
11. SureCut M3500 Radial Microtome-BASIC
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
... The BreatheX is a wearable CPAP ... treatment of sleep apnea. The lightweight BreatheX ... of therapy with its built-in, rechargeable battery, ... users will no longer need to be ...
Shandon Paraffin Block Cartons...
Medicine Products:
(Date:1/19/2017)... Huntington Beach, CA (PRWEB) , ... January 19, ... ... for Oral Health, is now offering treatments for patients with sleep apnea and ... far-reaching consequences for dental and physical health. Dr. Rassouli provides personalized care to ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... protection and financial planning services to communities throughout eastern Georgia, is embarking on ... heart disease. , Heart disease kills more Americans every year than anything else, ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages to prevent ... contest from Impact Teen Drivers and California Casualty. Entries from students aged 14-22 ... grants totaling $15,000 will be awarded for the best peer-to-peer messages sharing solutions ...
(Date:1/19/2017)... ... 19, 2017 , ... The 21st Century Cures Act’s Impact on Medical Devices:, ... 2016 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , ... to thrive this year? , The passage of the act means devicemakers will be ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... American Osteopathic College of Proctology) announced today the opening of 3 medical ... ( http://www.hemorrhoidsremovalcenterscalifornia.com ): Hemorrhoids Center of Los Angeles (Beverly Hills), Hemorrhoids Center ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... blood analysis instruments and consumables for the medical and ... discuss its financial results for the third quarter fiscal ... be at 4:15 p.m. ET on Thursday, January 26, ... third quarter fiscal year 2017 after the market closes ...
(Date:1/19/2017)... 2017 Shire plc (LSE: SHP, ... Food and Drug Administration (FDA) has acknowledged receipt of ... (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine salts ... treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected ... 2017, the designated Prescription Drug User Fee Act (PDUFA) ...
(Date:1/19/2017)... January 19, 2017 While ... serious about reducing the FDA,s regulatory strictness as ... the medical drug industry, many of the leading ... clinical trials and development of advanced drug treatments ... with recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: